DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Develops, produces, and markets human medicines, APIs, and veterinary drugs globally.

DEVA | IS

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte

Description

Established in 1958, DEVA Holding A.Ş. is a pharmaceutical company focused on the development, production, and marketing of medicinal products for human use and active pharmaceutical ingredients (APIs). The company also produces veterinary drugs. DEVA Holding maintains a diverse product portfolio, which includes antineoplastic and immunomodulating agents, and makes its products available on a global scale. Its international business operations are managed through various models, including distributorships, out-licensing, and direct supply agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2015-03-26 15:25
Genel Kurul Onayına Sunulacak Olan Bağımsız Denetim Kuruluşunun seçimi
Turkish 5.9 KB
2015-03-26 13:33
Şirketimiz tarafından ihraç edilen 100.000.000 TL nominal değerli TRSDEVA61615 …
Turkish 7.3 KB
2015-03-10 17:32
Kar payı ile ilgili Yönetim Kurulu kararı
Turkish 164.4 KB
2015-03-10 17:32
Kar payı ile ilgili Yönetim Kurulu kararı
Turkish 10.1 KB
2015-03-10 17:26
Sorumluluk Beyanı (Haziran 2016 öncesi)
Turkish 5.4 KB
2015-03-10 17:25
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 1.8 MB
2015-03-10 17:25
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 2.1 KB
2015-03-10 17:23
Statement of Financial Position (Balance Sheet)
Turkish 857.9 KB
2015-03-10 17:23
Statement of Financial Position (Balance Sheet)
Turkish 46.5 KB
2015-03-10 17:23
Profit or Loss and Other Comprehensive Income Statement
Turkish 857.9 KB
2015-03-10 17:23
Profit or Loss and Other Comprehensive Income Statement
Turkish 42.2 KB
2015-03-10 17:23
Cash Flow Statement
Turkish 857.9 KB
2015-03-10 17:23
Cash Flow Statement
Turkish 42.2 KB
2015-03-10 17:23
Statement of Changes in Equity
Turkish 857.9 KB
2015-03-10 17:23
Statement of Changes in Equity
Turkish 49.6 KB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Camp4 Therapeutics Corp Logo
Develops RNA-based therapeutics to amplify protein expression for genetic diseases.
United States of America
CAMP
Camurus Logo
Develops and commercializes long-acting medicines for severe and chronic diseases.
Sweden
CAMX
Candel Therapeutics, Inc. Logo
Develops viral immunotherapies to activate the immune system to fight cancer.
United States of America
CADL
Can-Fite BioPharma Ltd. Logo
Clinical-stage biopharma developing oral small-molecule drugs targeting the A3AR.
Israel
CANF
Cannabotech Ltd. Logo
Develops therapies by integrating cannabinoids and medicinal mushroom extracts.
Israel
CNTC
Cannovum Cannabis AG Logo
Licensed importer, wholesaler, and manufacturer of medical cannabis products.
Germany
27N0
Cantargia Logo
Develops antibody therapies targeting IL1RAP for cancer and inflammatory diseases.
Sweden
CANTA
Cantourage Group SE Logo
Produces and distributes EU-compliant medical cannabis from international partners.
Germany
HIGH
CAPRICOR THERAPEUTICS, INC. Logo
A clinical-stage biotech developing cell and exosome-based biologics for serious diseases.
United States of America
CAPR
A clinical-stage biotech developing regenerative medicines for heart failure.
United Kingdom
N/A

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.